PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
17 nov. 2023 08h00 HE
|
PaxMedica, Inc.
LOS ANGELES, Nov. 17, 2023 (GLOBE NEWSWIRE) -- via IBN –PaxMedica, Inc. (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announces that...
Nerve Repair and Regeneration Market Size Worth USD 14.21 Billion in 2032 | Emergen Research
15 nov. 2023 12h55 HE
|
Emergen Research
Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The global Nerve Repair and Regeneration Market will be worth USD 14.21 Billion by 2032, according to a current analysis by Emergen Research. The growth...
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
31 oct. 2023 08h00 HE
|
PaxMedica, Inc.
TARRYTOWN, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological...
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
13 oct. 2023 09h30 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Synthetic Cannabinoids Market Size & Share to Surpass $6.7 Billion by 2030 | Vantage Market Research
29 août 2023 07h36 HE
|
Vantage Market Research
WASHINGTON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Synthetic Cannabinoids Market has been steadily growing over the years due to increasing demand for...
Global Synthetic Cannabinoids Market Size Revenue Forecasted to Surpass $12.4 Billion by 2030, At a CAGR of 21.81%
21 août 2023 07h20 HE
|
Zion Market Research
New York, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Synthetic Cannabinoids Market By Indication (Nausea/Vomiting, Pain Management, And...
Central Nervous System Therapeutics Market to hit USD 238.8 billion by 2032, says Global Market Insights Inc.
20 août 2023 20h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 20, 2023 (GLOBE NEWSWIRE) -- Central Nervous System Therapeutics Market size is expected to be worth USD 238.8 billion by 2032. The growing investments in R&D...
Stem Cell Therapy Market Size & Share to Surpass $831.9 Mn by 2030 | Vantage Market Research
14 août 2023 05h00 HE
|
Vantage Market Research
WASHINGTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Stem Cell Therapy Market has been steadily growing due to the increasing importance of medical advancements...
NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
08 août 2023 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Enhancing Care: Expansion of Alpers Disease Treatment Market Size On its Path to US$ 1.90 Billion by 2030, at a 4.57% of CAGR.
07 juin 2023 09h13 HE
|
Zion Market Research
Houston, TX, June 07, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Alpers Disease Treatment Market By Diagnosis (Molecular Genetic Testing, Laboratory...